Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX $456.69)
- $456.69 P/E (TTM): 31.26X Cap: $117.06B
- View VRTX Profile
- View Questions on VRTX

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $490.16)
- $490.16 P/E (TTM): 63.68X Cap: $174.07B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $456.69)
- $456.69 P/E (TTM): 31.26X Cap: $117.06B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $230.11)
- $230.11 P/E (TTM): 100.08X Cap: $406.87B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $240.40)
- $240.40 P/E (TTM): 22.24X Cap: $577.48B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $990.33)
- $990.33 P/E (TTM): 43.73X Cap: $927.56B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $115.79)
- $115.79 P/E (TTM): 16.52X Cap: $286.97B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $167.56)
- $167.56 P/E (TTM): 20.63X Cap: $8.27B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $608.41)
- $608.41 P/E (TTM): 49.59X Cap: $49.28B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $67.37)
- $67.37 P/E (TTM): 27.68X Cap: $7.94B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $95.94)
- $95.94 P/E (TTM): 15.42X Cap: $19.37B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.24)
- $24.24 P/E (TTM): 14.39X Cap: $2.96B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $29.38)
- $29.38 P/E (TTM): 390.05X Cap: $244.96B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Vertex Pharmaceuticals Incorporated (VRTX $456.69)
- $456.69 P/E (TTM): 31.26X Cap: $117.06B
- View VRTX Profile
- View Questions on VRTX
CRISPR Therapeutics AG (CRSP $56.50)
- $56.50 Cap: $5.50B
- View CRSP Profile
- View Questions on CRSP

Q: What is your opinion regarding the future of CRSP? Buy, sell, hold?

Read Answer Asked by Judith on May 21, 2025

Vertex Pharmaceuticals Incorporated (VRTX $456.69)
- $456.69 P/E (TTM): 31.26X Cap: $117.06B
- View VRTX Profile
- View Questions on VRTX

Q: May I please get your thoughts on this company? I like their new non-opioid pain killer that was just approved by the FDA for a strong growth prospect. I am curious what you think about the existing business and the fundamentals/financials of the company. Thanks.

Read Answer Asked by Marco on February 14, 2025